CTRI/2021/08/035431已完成未知
An Open Label, Observational, Prospective, Non-Comparative, Multicentre Real World Study To Evaluate The Clinical Effectiveness And Safety Of Formoterol/Budesonide FDC Delivered Through Synchrobreathe In Patients With Chronic Obstructive Pulmonary Disease - EMERGE
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Cipla Ltd
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1)Patient willing to provide signed data sharing consent form. AND
- •2)Patients of either gender of age 40 years or above with documented diagnosis of COPD as per GOLD 2020 guidelines and CAT score of more than 10 units. AND
- •3)Patients prescribed formoterol/budesonide FDC through Synchrobreathe inhaler for COPD due to any of the following reason:
- •a) Patient not controlled with current treatment or current ICS/LABA and requires the addition of formoterol/budesonide FDC.
- •b) Unable to use or not satisfied with the previously prescribed inhaler for taking Formoterol/Budesonide FDC.
- •4)Patients suitable to share data for the study as per Investigator’s discretion
排除标准
- •1)Hypersensitivity to study drug or any of its components.
- •2)Acute exacerbation of COPD within past 1 month.
- •3)Current or previous experience with the use of Synchrobreathe.
研究者
相似试验
已完成
4 期
A study to assess the control of asthma and ease of use of inhaler device (Synchrobreathe) with the medicine (Seroflo-Salmetrol/Fluticasone FDC) in routine clinical practiceCTRI/2018/12/016629Cipla Ltd490
已完成
4 期
Evaluation of efficacy and safety of Itraconazole capsule and Amorolfine cream in skin infectionsCTRI/2019/04/018560Rajiv Gandhi Medical College and Chhatrapati Shivaji Maharaj Hospital
已完成
4 期
A study to assess how effective and safe is the moisturizer for patients having acne who areprescribed isotretinoiCTRI/2019/07/020458Cipla Ltd200
已完成
4 期
An observational real world effectiveness study of Fluticasone/Formoterol FDC(Maxiflo®)Rotacaps(100/6 mcg and 250/6 mcg) when taken through Revolizer® inpatients with persistent AsthmaCTRI/2014/11/005164Cipla Ltd400
已完成
4 期
An observational real world effectiveness study of Triohale® taken through metered dose Inhaler or dry powder inhaler in patients with COPD.CTRI/2015/01/005453Cipla Ltd300